Survival Of Patients Under Arv

HIV/AIDS is a health problem in Côte d'Ivoire. With a prevalence rate of 4.7% in the general population aged between 15-49 years old (AIS CI-2005), the epidemic is generalized. As part of the second phase of the Global Fund, the measurement of indicators is a priority for the country. Where the conduct of an evaluation survey that will, in comparison with the baseline (February 2008), to assess the impact of the program The objective of the survey are: (i) to Evaluate the survival rate of people living with HIV after 12-18 months of antiretroviral treatment, (ii) to assess the main determinants of survival of patients on ARV and (iii) to determine the percentage of HIV-negative children (18-24 months) born to seropositive mothers. The results of the study showed that the survival rate of 12 months is estimated at 75% for patients placed on ARV between July 2007 and April 2008 against 71.7% for patients placed on ARV between January 2006 and December 2006, an Increase of 3.3%. Regarding children born to seropositive mothers, the proportion of children tested between 18-24 months is low (11%). The percentage of HIV-negative children born to HIV-positive mothers is estimated to 61.2%

Autorentext

Arsène Kouablan Adou is a demographer, holder of a Master's degree in demography from the Institute for Demographic Training and Research (IFORD, Cameroon). He is the Head of the Research and Evaluation Division at the Ivorian Association for Family Welfare Welfare (AIBEF), the Member Association of the IPPF. He is also a member of UAPS and IUSSP.

Klappentext

HIV/AIDS is a health problem in Côte d'Ivoire. With a prevalence rate of 4.7% in the general population aged between 15-49 years old (AIS CI-2005), the epidemic is generalized. As part of the second phase of the Global Fund, the measurement of indicators is a priority for the country. Where the conduct of an evaluation survey that will, in comparison with the baseline (February 2008), to assess the impact of the program The objective of the survey are: (i) to Evaluate the survival rate of people living with HIV after 12-18 months of antiretroviral treatment, (ii) to assess the main determinants of survival of patients on ARV and (iii) to determine the percentage of HIV-negative children (18-24 months) born to seropositive mothers. The results of the study showed that the survival rate of 12 months is estimated at 75% for patients placed on ARV between July 2007 and April 2008 against 71.7% for patients placed on ARV between January 2006 and December 2006, an Increase of 3.3%. Regarding children born to seropositive mothers, the proportion of children tested between 18-24 months is low (11%). The percentage of HIV-negative children born to HIV-positive mothers is estimated to 61.2%